Source comparison
Melanotan-2 Erectile Function Results Timeline: Comparison
Mechanism Smooth muscle relaxation via cGMP pathway Central arousal via MC4R activation Dopamine receptor agonism MT-2 operates upstream of vascular effects. Arousal precedes blood flow Onset Time 30–60 minutes 48–72 hours for noticeable effect; 7–14 days for
This comparison does not assign a generated winner or score.
- Mechanism
- Smooth muscle relaxation via cGMP pathway
- Central arousal via MC4R activation
- Dopamine receptor agonism
- MT-2 operates upstream of vascular effects. Arousal precedes blood flow
- Onset Time
- 30–60 minutes
- 48–72 hours for noticeable effect; 7–14 days for peak
- 20–30 minutes
- MT-2 requires cumulative dosing; single-dose effects are transient
- Duration of Effect
- 4–6 hours
- 18–24 hours per dose; sustained with daily use
- 2–3 hours
- MT-2 maintains effect beyond plasma half-life due to receptor occupancy
- Dependency on Arousal
- Requires sexual stimulation
- Produces spontaneous arousal independent of stimuli
- Requires sexual context
- MT-2 creates arousal where none exists. This is neurogenic, not psychological
- Side Effects
- Headache, flushing, nasal congestion
- Nausea, facial flushing, hyperpigmentation
- Nausea, dizziness, syncope
- MT-2 nausea is dose-dependent and temporary; skin darkening is permanent until melanin turnover
- Tolerance Development
- Minimal
- Develops after 3–4 weeks daily use
- Cycling protocols (5 on / 2 off) prevent MC4R downregulation
- The key differentiator: PDE5 inhibitors treat vascular insufficiency; MT-2 treats arousal suppression. If erectile dysfunction stems from poor blood flow (atherosclerosis, diabetes), MT-2 won't compensate. If it stems from low libido, psychological inhibition, or neurological arousal deficits, MT-2 addresses the root mechanism.